Fetal fibronectin does not affect outcomes of preterm labor

Use of fetal fibronectin in the assessment of women presenting to labor and delivery units with symptoms of preterm labor does not affect the gestational age at delivery, frequency of use of medical interventions, length of stay in labor and delivery, or rate of inpatient admissions. (Level of evidence [LOE]=1b)

Use of fetal fibronectin in the assessment of women presenting to labor and delivery units with symptoms of preterm labor does not affect the gestational age at delivery, frequency of use of medical interventions, length of stay in labor and delivery, or rate of inpatient admissions. (Level of evidence [LOE]=1b)

Use of fetal fibronectin in the assessment of women presenting to labor and delivery units with symptoms of preterm labor does not affect the gestational age at delivery, frequency of use of medical interventions, length of stay in labor and delivery, or rate of inpatient admissions. (Level of evidence [LOE]=1b)